Hydroxamic acid derivatives
USRE46144E1 · kind E1 · reissue
23Cited by
2References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 2015 |
| Grant date | Sep 13, 2016 |
| Priority date | — |
| Expiry date | Dec 17, 2035 |
Classification
- Technology area (CPC —)General
Abstract
The disclosure includes hydroxamic compounds of Formula I: (I) wherein P, Z, and m are defined herein. Also disclosed is a method for treating a neoplastic disease or an immune disease with these compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.